ProQR Therapeutics (PRQR) Q3 2024 Earnings
PRQR·Reported November 7, 2024·Before market open
ProQR Therapeutics reported Q3 2024 revenue of $4.2M, missed analyst consensus of $7.0M by $2.8M. Diluted EPS came in at $-0.11, beat the $-0.12 consensus by $0.01.
Revenue
$4.2Mmissed by $2.8M
Consensus: $7.0MDiluted EPS
$-0.11beat by $0.01
Consensus: $-0.12
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q3 2024 Earnings FAQ
Common questions about ProQR Therapeutics's Q3 2024 earnings report.
ProQR Therapeutics (PRQR) reported Q3 2024 earnings on November 7, 2024 before market open.
ProQR Therapeutics reported revenue of $4.2M and diluted EPS of $-0.11 for Q3 2024.
Revenue missed the consensus estimate of $7.0M by $2.8M. EPS beat the consensus estimate of $-0.12 by $0.01.